Insider Buying: Myomo (NYSEAMERICAN:MYO) Director Purchases 40,002 Shares of Stock

Posted by on Jun 9th, 2026

Myomo, Inc. (NYSEAMERICAN:MYO – Get Free Report) Director Thomas Kirk bought 40,002 shares of the company’s stock in a transaction on Friday, June 5th. The stock was bought at an average price of $1.27 per share, for a total transaction of $50,802.54. Following the completion of the purchase, the director directly owned 693,865 shares in the company, valued at approximately $881,208.55. This represents a 6.12% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

Myomo Trading Up 2.3%

MYO stock traded up $0.03 during mid-day trading on Tuesday, reaching $1.31. The company had a trading volume of 902,827 shares, compared to its average volume of 492,767. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.73 and a quick ratio of 2.36. The company has a market capitalization of $50.62 million, a PE ratio of -3.64 and a beta of 1.47. The firm has a 50 day moving average of $0.87 and a 200 day moving average of $0.87. Myomo, Inc. has a 12 month low of $0.61 and a 12 month high of $2.99.

Hedge Funds Weigh In On Myomo

Hedge funds and other institutional investors have recently modified their holdings of the business. Bank of America Corp DE boosted its stake in shares of Myomo by 93.6% during the third quarter. Bank of America Corp DE now owns 30,412 shares of the company’s stock valued at $27,000 after purchasing an additional 14,705 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of Myomo by 103.1% during the fourth quarter. Wells Fargo & Company MN now owns 38,707 shares of the company’s stock valued at $35,000 after purchasing an additional 19,646 shares in the last quarter. Invesco Ltd. bought a new position in shares of Myomo during the second quarter valued at approximately $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Myomo during the second quarter valued at approximately $38,000. Finally, Jane Street Group LLC bought a new position in shares of Myomo during the fourth quarter valued at approximately $64,000. 44.99% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on MYO shares. Ascendiant Capital Markets upped their target price on shares of Myomo from $9.50 to $10.00 and gave the stock a “buy” rating in a research note on Monday. Craig Hallum restated a “buy” rating on shares of Myomo in a research note on Tuesday, March 10th. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Myomo presently has an average rating of “Buy” and a consensus target price of $7.67.

Check Out Our Latest Research Report on MYO

About Myomo

(Get Free Report)

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.

Featured Stories

Insider Buying and Selling by Quarter for Myomo (NYSEAMERICAN:MYO)

Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.